Cullinan Associates Inc Novo Nordisk A S Transaction History
Cullinan Associates Inc
- $1.81 Billion
- Q3 2024
A detailed history of Cullinan Associates Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Cullinan Associates Inc holds 9,000 shares of NVO stock, worth $945,540. This represents 0.06% of its overall portfolio holdings.
Number of Shares
9,000
Previous 9,400
4.26%
Holding current value
$945,540
Previous $1.34 Million
20.13%
% of portfolio
0.06%
Previous 0.08%
Shares
8 transactions
Others Institutions Holding NVO
# of Institutions
1,954Shares Held
320MCall Options Held
5.49MPut Options Held
7.78M-
Jennison Associates LLC20.2MShares$2.12 Billion1.5% of portfolio
-
Morgan Stanley New York, NY14.4MShares$1.51 Billion0.13% of portfolio
-
Bank Of America Corp Charlotte, NC14.3MShares$1.51 Billion0.14% of portfolio
-
Ken Fisher Fisher Asset Management, LLC | Camas, Wa13.3MShares$1.4 Billion0.65% of portfolio
-
Fayez Sarofim & CO Houston, TX12.2MShares$1.28 Billion3.76% of portfolio
About NOVO NORDISK A S
- Ticker NVO
- Exchange OTC
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 2,257,289,984
- Market Cap $237B
- Description
- Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...